Year: 2016
Type: article
Study design: Observational Study
Abstract: Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to persistently suppress viremia. Because accumulating evidence suggests that HIV controllers generate antibodies with enhanced capacity to drive antibody-dependent cellular cytotoxicity (ADCC) that may contribute to viral containment, we profiled an array of extra-neutralizing antibody effector functions across HIV-infected populations with varying degrees of viral control to define the characteristics of antibodies associated with spontaneous control. While neither the overall magnitude of antibody titer nor individual effector functions were increased in ECs, a more functionally coordinated innate immune-recruiting response was observed. Specifically, ECs demonstrated polyfunctional humoral immune responses able to coordinately recruit ADCC, other NK functions, monocyte and neutrophil phagocytosis, and complement. This functionally coordinated response was associated with qualitatively superior IgG3/IgG1 responses, whereas HIV-specific IgG2/IgG4 responses, prevalent among viremic subjects, were associated with poorer overall antibody activity. Rather than linking viral control to any single activity, this study highlights the critical nature of functionally coordinated antibodies in HIV control and associates this polyfunctionality with preferential induction of potent antibody subclasses, supporting coordinated antibody activity as a goal in strategies directed at an HIV-1 functional cure.
Source: PLoS Pathogens
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,043
Awards: Demystifying the antiviral activity of the IgG3+ antibody response, Applying High-Performance Protein Engineering Tools to HIV Immunogen Design, The General Hospital Corporation d/b/a Massachusetts General Hospital - to support a project designed to define the baseline status of the immune system immediately before, and during the earliest events in HIV infectio..., The General Hospital Corporation d/b/a Massachusetts General Hospital - to define, induce, and evaluate the protection afforded by potent innate immune-recruiting antibodies.., Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Tuning Fc-effector functions of HIV-specific antibodies
OpenAlex ID: W2229789789
